Literature DB >> 12022348

Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.

Lena Björnådal1, Eva Baecklund, Li Yin, Fredrik Granath, Lars Klareskog, Anders Ekbom.   

Abstract

OBJECTIVE: To assess changes in mortality in patients with rheumatoid arthritis (RA) from 1964 to 1995.
METHODS: A population based cohort of 46,917 patients with RA was identified from 1964 to 1994, using the Swedish Hospital Discharge Register, and followed until 1995 through linkage to the Cause of Death Register. Mortality was separately analyzed in each inclusion period (1964-75, 1975-84, 1985-94). The relative risk of death was estimated as standardized mortality ratio (SMR) using the Swedish population as a reference
RESULTS: All-cause mortality was increased twice the expected (SMR = 2.03, 95% CI 2.00, 2.05). Coronary artery disease was the major cause of death and mortality was increased by 80% (SMR = 1.79, 95% CI 1.75, 1.83). Females with RA aged 20-39 at first discharge had a more than 5-fold increased risk of coronary death (SMR = 5.48, 95% CI 3.45-5.71). From 1975 patients with RA had decreasing all-cause mortality. This decline was most pronounced in patients aged 40-59 at first discharge, where SMR was 2.68 (95% CI 2.45, 2.92) from 1964 to 1974 compared to SMR 1.63 (95% CI 1.37, 1.92) from 1985 to 1994.
CONCLUSION: The elevated mortality rates in RA patients compared to the general population have decreased during the last 20 years, possibly due to an increased access to specialized rheumatology care. An excess risk for death in coronary artery disease was, however, present in RA patients, especially patients with early onset of disease.

Entities:  

Mesh:

Year:  2002        PMID: 12022348

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  38 in total

Review 1.  Rheumatoid arthritis in 2003: where are we now with treatment?

Authors:  M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study.

Authors:  Jeffrey A Sparks; Shun-Chiao Chang; Katherine P Liao; Bing Lu; Alexander R Fine; Daniel H Solomon; Karen H Costenbader; Elizabeth W Karlson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-06       Impact factor: 4.794

Review 3.  Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.

Authors:  Eleanor M Heather; Katherine Payne; Mark Harrison; Deborah P M Symmons
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

Review 4.  Introduction/overview on clinical registries.

Authors:  D D Gladman; A Menter
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

5.  Patterns of cardiovascular risk in rheumatoid arthritis.

Authors:  D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

Review 6.  What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

Authors:  W G Dixon; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2007-01-24       Impact factor: 19.103

7.  An inverse association between self-reported arthritis and mortality in the elderly: findings from the national long-term care survey.

Authors:  Alexander M Kulminski; Irina V Kulminskaya; Svetlana V Ukraintseva; Kenneth Land; Anatoli I Yashin
Journal:  Rejuvenation Res       Date:  2008-02       Impact factor: 4.663

8.  Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.

Authors:  Tim Bongartz; Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2010-06

Review 9.  What Has Changed in the Treatment of Psoriatic Arthritis After COVID-19?

Authors:  Yaşar Keskin; Gökhan Koz; Kemal Nas
Journal:  Eurasian J Med       Date:  2021-06

10.  Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database.

Authors:  Hans Petri; Debra Maldonato; Noah Jamie Robinson
Journal:  BMC Musculoskelet Disord       Date:  2010-10-25       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.